Medarex, Zycos Enter 50-50 Deal To Make Antibodies For Cancer
By Kim Coghill
Wednesday, January 23, 2002
Medarex Inc. and Zycos Inc. entered an equal partnership to discover cancer drugs using technologies developed by each company.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.